CXL and the treatment of keratoconus (C-100432)

CPD
1
30 April 2020
Spring 2020

Consultant Ophthalmologist Damian Lake looks at the history of corneal collagen cross-linking in treating keratoconus, the current indications for its use, and the most up-to-date refinements to the procedure.

Domains covered

Communication Clinical practice

Keratoconus, which causes the cornea to become thinner and steeper, is perhaps most commonly associated with eye rubbing. Regular, traumatic vicissitude of eye rubbing can weaken the cornea, creating bulging, thinning and structural failure. The likely pathogenesis 
is multifactorial, with a wide range of genetic loci suggesting the disease is dependent on external influences that lead to initiation and progression. 

Associated ocular and systemic conditions include, but are not limited to, atopic eczema, asthma, allergic eye diseases, Down’s syndrome, collagen vascular diseases and retinitis pigmentosa. Keratoconus is known to affect between one in 400 and one in 2000 – mainly young – people worldwide (Godefrooij et al, 2017). 

Sign in to continue

Forgotten password?
Register

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

This follows the same format as Mr Balaggan and Professor Gilmartin’s popular combined talks, with patients providing learning opportunities.

COVID-19 and its impact on eyecare: a review